Y
Yimei
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| GHK-Cu | B | 13 | 7.0 | 5.0 | 8.0 | 25 Nov 2025 |
| Retatrutide | E | 40 | 6.6 | 0.0 | 9.8 | 20 Jun 2025 |
| TB-500 | X | 1 | 7.7 | 7.7 | 7.7 | 25 May 2026 |
| AHK-CU | X | 1 | 4.1 | 4.1 | 4.1 | 21 May 2025 |
| AICAR | B | 3 | 6.1 | 4.7 | 7.9 | 23 May 2026 |
| Alprostadil | B | 3 | 7.4 | 6.1 | 8.9 | 21 May 2026 |
| Anavar (Oxandrolone) | B | 4 | 6.4 | 5.5 | 8.0 | 21 May 2026 |
| Boldenone Cypionate | B | 3 | 6.5 | 6.0 | 7.3 | 24 May 2026 |
| Bronchogen | B | 4 | 7.0 | 5.9 | 8.4 | 24 May 2026 |
| Cerebrolysin | B | 3 | 5.6 | 5.3 | 6.2 | 24 May 2026 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | B | 5 | 7.6 | 6.5 | 10.0 | 19 Jan 2026 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | B | 2 | 6.6 | 5.4 | 7.7 | 26 Jan 2026 |
| DSIP | B | 4 | 6.9 | 5.6 | 9.1 | 19 Jan 2026 |
| Equipoise (Boldenone Undecylenate) | B | 4 | 7.2 | 5.5 | 8.7 | 21 May 2026 |
| Estradiol Cypionate | B | 5 | 6.5 | 5.1 | 8.0 | 19 Jan 2026 |
| Finasteride | B | 2 | 7.2 | 6.1 | 8.3 | 17 May 2026 |
| Flibanserin | B | 4 | 5.6 | 2.5 | 7.9 | 23 May 2026 |
| GHRP-6 Acetate | B | 5 | 7.6 | 5.9 | 9.9 | 26 Jan 2026 |
| HMG | B | 4 | 7.1 | 5.5 | 9.2 | 21 May 2026 |
| KPV Oral | B | 4 | 6.8 | 5.9 | 7.4 | 25 May 2026 |
| Lipo-B 216mg | B | 3 | 6.4 | 2.9 | 8.5 | 24 May 2026 |
| MK-677 (Ibutamoren) | B | 3 | 7.1 | 7.0 | 7.2 | 24 May 2026 |
| N-Acetyl Epitalon Amidate | X | 1 | 9.2 | 9.2 | 9.2 | 7 May 2025 |
| Ovagen | X | 1 | 4.1 | 4.1 | 4.1 | 13 Jun 2025 |
| PE 22-28 | B | 5 | 6.4 | 4.9 | 9.7 | 24 May 2026 |
| Pinealon | X | 1 | 5.0 | 5.0 | 5.0 | 17 Dec 2024 |
| Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | X | 1 | 4.2 | 4.2 | 4.2 | 8 Jul 2025 |
| Retatrutide 30mg Pen Kit | B | 5 | 7.7 | 6.8 | 8.2 | 19 Jan 2026 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X | 1 | 5.4 | 5.4 | 5.4 | 2 Apr 2025 |
| Selank | B | 4 | 5.1 | 3.6 | 7.8 | 26 Jan 2026 |
| SNAP-8 | X | 1 | 6.2 | 6.2 | 6.2 | 17 Dec 2024 |
| SS-31 | B | 4 | 6.2 | 5.3 | 6.8 | 24 May 2026 |
| Sustanon Blend Raw | B | 2 | 5.6 | 4.6 | 6.6 | 19 Jan 2026 |
| T4 (Levothyroxine) | B | 3 | 5.9 | 4.9 | 6.5 | 24 May 2026 |
| Tadalafil (Cialis) | B | 3 | 6.7 | 6.6 | 6.8 | 17 May 2026 |
| Tamoxifen (Nolvadex) | B | 5 | 5.8 | 4.6 | 8.2 | 23 May 2026 |
| Tren Hex | X | 1 | 6.4 | 6.4 | 6.4 | 17 Dec 2024 |
| Trenbolone Acetate Raw | B | 5 | 7.4 | 6.7 | 8.1 | 21 May 2026 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | Retatrutide | 7.5 | 15mg | 15.6mg | +4.0% | 99.70% | Lab G |
| 25 May 2026 | Flibanserin | 6.3 | 50mg | 59.4mg | +18.8% | 96.39% | Lab A |
| 25 May 2026 | Tamoxifen (Nolvadex) | 7.3 | 20mg | 24.5mg | +22.3% | 99.64% | Lab B |
| 25 May 2026 | Trenbolone Acetate Raw | 8.0 | 5g | 5.7g | +13.3% | 99.42% | Lab D |
| 24 May 2026 | Boldenone Cypionate | 5.7 | 100mg/ml | 103.3mg/ml | +3.3% | 95.94% | Lab A |
| 24 May 2026 | Bronchogen | 5.9 | 50mg | 53.7mg | +7.5% | 96.69% | Lab C |
| 24 May 2026 | Bronchogen | 8.2 | 20mg | 22.8mg | +13.8% | 97.68% | Lab D |
| 24 May 2026 | Tadalafil (Cialis) | 6.7 | 20mg | 23.2mg | +16.0% | 97.30% | Lab F |
| 24 May 2026 | Retatrutide | 6.3 | 10mg | 10.8mg | +8.0% | 99.60% | Lab G |
| 24 May 2026 | GHK-Cu | 5.0 | 50mg | 58mg | +16.0% | 99.70% | Lab G |
| 24 May 2026 | Retatrutide | 8.0 | 10mg | 10.1mg | +1.0% | 99.90% | Lab E |
| 24 May 2026 | Retatrutide | 8.0 | 5mg | 4.84mg | -3.2% | 99.90% | Lab E |
| 24 May 2026 | Flibanserin | 5.6 | 100mg | 99.6mg | -0.4% | 97.18% | Lab A |
| 24 May 2026 | PE 22-28 | 5.8 | 15mg | 18.3mg | +22.0% | 98.36% | Lab E |
| 24 May 2026 | SS-31 | 7.7 | 2mg | 2.1mg | +5.8% | 96.85% | Lab B |
| 24 May 2026 | T4 (Levothyroxine) | 6.6 | 25mg | 28.5mg | +13.8% | 97.08% | Lab A |
| 24 May 2026 | Tamoxifen (Nolvadex) | 5.2 | 10mg | 11.1mg | +11.0% | 99.05% | Lab E |
| 24 May 2026 | Retatrutide | 3.5 | 10mg | 8.76mg | -12.4% | 98.54% | Lab E |
| 24 May 2026 | Retatrutide | 9.1 | 50mg | 48mg | -4.0% | 99.53% | Lab E |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.8 | 2mg | 2.0mg | -1.3% | 97.47% | Lab F |
| 24 May 2026 | Estradiol Cypionate | 7.3 | 200mg/ml | 196.6mg/ml | -1.7% | 99.38% | Lab A |
| 24 May 2026 | KPV Oral | 5.4 | 25mg | 29.0mg | +15.9% | 97.24% | Lab F |
| 24 May 2026 | Lipo-B 216mg | 4.8 | 200mg/ml | 199.8mg/ml | -0.1% | 99.86% | Lab A |
| 24 May 2026 | AICAR | 6.7 | 50mg | 43.2mg | -13.5% | 95.64% | Lab C |
| 24 May 2026 | Alprostadil | 8.0 | 50mg | 57.0mg | +14.0% | 95.62% | Lab F |
| 24 May 2026 | Bronchogen | 10.0 | 30mg | 36.3mg | +21.1% | 96.40% | Lab B |
| 24 May 2026 | Cerebrolysin | 6.5 | 2mg | 1.8mg | -12.1% | 97.98% | Lab F |
| 24 May 2026 | Cerebrolysin | 4.0 | 15mg | 15.0mg | +0.1% | 95.19% | Lab C |
| 24 May 2026 | AHK-CU | 5.4 | 30mg | 26.6mg | -11.3% | 97.76% | Lab G |
| 24 May 2026 | Boldenone Cypionate | 6.8 | 300mg/ml | 308.3mg/ml | +2.8% | 96.77% | Lab B |
| 24 May 2026 | GHRP-6 Acetate | 6.2 | 5mg | 5.4mg | +8.3% | 98.12% | Lab F |
| 24 May 2026 | Retatrutide 30mg Pen Kit | 7.3 | 50mg | 58.0mg | +16.0% | 98.85% | Lab G |
| 24 May 2026 | Trenbolone Acetate Raw | 8.1 | 500g | 555.6g | +11.1% | 96.21% | Lab E |
| 23 May 2026 | Finasteride | 8.0 | 20mg | 19.7mg | -1.4% | 96.34% | Lab B |
| 23 May 2026 | GHRP-6 Acetate | 10.0 | 10mg | 8.9mg | -11.3% | 98.20% | Lab B |
| 23 May 2026 | Tren Hex | 7.5 | 250mg/ml | 225.9mg/ml | -9.6% | 98.23% | Lab G |
| 23 May 2026 | AICAR | 8.2 | 15mg | 13.4mg | -10.4% | 96.15% | Lab F |
| 23 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 7.2 | 15mg | 16.1mg | +7.1% | 98.14% | Lab F |
| 23 May 2026 | HMG | 6.4 | 2mg | 1.8mg | -8.4% | 95.06% | Lab C |
| 23 May 2026 | Ovagen | 6.1 | 10mg | 9.2mg | -8.1% | 95.91% | Lab F |
| 23 May 2026 | SS-31 | 6.7 | 30mg | 27.7mg | -7.5% | 96.95% | Lab C |
| 21 May 2026 | Anavar (Oxandrolone) | 5.9 | 50mg | 62.0mg | +23.9% | 98.42% | Lab G |
| 21 May 2026 | Bronchogen | 7.4 | 50mg | 45.7mg | -8.7% | 96.18% | Lab B |
| 21 May 2026 | HMG | 7.3 | 30mg | 32.7mg | +9.0% | 98.78% | Lab E |
| 21 May 2026 | Equipoise (Boldenone Undecylenate) | 7.6 | 100mg/ml | 123.9mg/ml | +23.9% | 95.93% | Lab G |
| 21 May 2026 | Flibanserin | 4.5 | 10mg | 11.3mg | +13.4% | 95.37% | Lab F |
| 21 May 2026 | KPV Oral | 6.0 | 10mg | 11.2mg | +12.1% | 99.72% | Lab B |
| 21 May 2026 | Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | 4.7 | 100mg/ml | 98.5mg/ml | -1.5% | 95.28% | Lab B |
| 20 May 2026 | AICAR | 5.4 | 10mg | 11.1mg | +11.3% | 95.91% | Lab F |
| 20 May 2026 | Boldenone Cypionate | 5.2 | 200mg/ml | 195.1mg/ml | -2.4% | 96.87% | Lab E |
| 20 May 2026 | Cerebrolysin | 5.4 | 10mg | 11.7mg | +17.5% | 99.87% | Lab G |
| 20 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.4 | 2mg | 2.2mg | +11.1% | 96.91% | Lab C |
| 20 May 2026 | Flibanserin | 6.1 | 20mg | 18.1mg | -9.4% | 99.20% | Lab E |
| 19 May 2026 | GHRP-6 Acetate | 6.9 | 10mg | 8.6mg | -13.9% | 95.08% | Lab E |
| 19 May 2026 | MK-677 (Ibutamoren) | 6.0 | 50mg | 60.4mg | +20.9% | 98.80% | Lab E |
| 17 May 2026 | Equipoise (Boldenone Undecylenate) | 5.4 | 300mg/ml | 293.7mg/ml | -2.1% | 97.45% | Lab E |
| 17 May 2026 | HMG | 6.8 | 15mg | 13.9mg | -7.1% | 99.29% | Lab C |
| 17 May 2026 | Sustanon Blend Raw | 5.1 | 500g | 608.9g | +21.8% | 95.10% | Lab D |
| 17 May 2026 | Trenbolone Acetate Raw | 7.2 | 500g | 611.6g | +22.3% | 97.06% | Lab A |
| 29 Jan 2026 | Lipo-B 216mg | 9.0 | 100mg/ml | 100.5mg/ml | +0.5% | 99.10% | Lab G |
| 29 Jan 2026 | T4 (Levothyroxine) | 6.8 | 10mg | 11.1mg | +10.9% | 99.27% | Lab E |
| 26 Jan 2026 | DSIP | 8.0 | 10mg | 10.9mg | +9.2% | 96.66% | Lab A |
| 19 Jan 2026 | Anavar (Oxandrolone) | 7.5 | 50mg | 54.1mg | +8.1% | 96.05% | Lab D |
| 19 Jan 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 7.1 | 5mg | 5.8mg | +16.0% | 97.06% | Lab C |
| 19 Jan 2026 | GHRP-6 Acetate | 8.1 | 50mg | 48.9mg | -2.2% | 95.63% | Lab D |
| 19 Jan 2026 | Lipo-B 216mg | 7.0 | 100mg/ml | 109.6mg/ml | +9.6% | 98.41% | Lab F |
| 19 Jan 2026 | T4 (Levothyroxine) | 4.0 | 20mg | 17.2mg | -14.0% | 97.16% | Lab A |
| 9 Jan 2026 | Alprostadil | 9.8 | 2mg | 2.4mg | +20.3% | 99.05% | Lab E |
| 9 Jan 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 8.3 | 2mg | 1.8mg | -10.4% | 95.63% | Lab G |
| 9 Jan 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 7.8 | 30mg | 33.9mg | +13.1% | 97.50% | Lab G |
| 9 Jan 2026 | PE 22-28 | 7.5 | 10mg | 11.4mg | +14.3% | 95.67% | Lab D |
| 7 Jan 2026 | Equipoise (Boldenone Undecylenate) | 6.6 | 100mg/ml | 90.1mg/ml | -9.9% | 97.54% | Lab E |
| 7 Jan 2026 | Estradiol Cypionate | 8.7 | 250mg/ml | 259.1mg/ml | +3.7% | 98.63% | Lab E |
| 7 Jan 2026 | Selank | 4.7 | 20mg | 23.8mg | +18.8% | 98.17% | Lab F |
| 6 Jan 2026 | DSIP | 8.2 | 50mg | 54.5mg | +9.1% | 95.18% | Lab G |
| 6 Jan 2026 | KPV Oral | 7.6 | 20mg | 19.1mg | -4.3% | 96.66% | Lab E |
| 6 Jan 2026 | PE 22-28 | 6.1 | 30mg | 34.4mg | +14.7% | 99.80% | Lab A |
| 6 Jan 2026 | Trenbolone Acetate Raw | 6.9 | 500g | 614.2g | +22.8% | 97.98% | Lab A |
| 29 Dec 2025 | Anavar (Oxandrolone) | 7.8 | 25mg | 29.9mg | +19.5% | 95.27% | Lab E |
| 29 Dec 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 8.7 | 15mg | 15.6mg | +3.9% | 95.81% | Lab A |
| 29 Dec 2025 | Finasteride | 6.2 | 100mg | 113.1mg | +13.1% | 99.40% | Lab C |
| 29 Dec 2025 | GHRP-6 Acetate | 7.0 | 15mg | 16.3mg | +8.9% | 98.76% | Lab A |
| 29 Dec 2025 | HMG | 9.3 | 15mg | 15.2mg | +1.1% | 99.30% | Lab A |
| 29 Dec 2025 | N-Acetyl Epitalon Amidate | 7.0 | 50mg | 46.1mg | -7.8% | 96.70% | Lab A |
| 29 Dec 2025 | Retatrutide 30mg Pen Kit | 7.7 | 5mg | 4.6mg | -7.3% | 95.22% | Lab C |
| 29 Dec 2025 | Selank | 5.1 | 15mg | 15.3mg | +2.1% | 99.41% | Lab A |
| 29 Dec 2025 | Tamoxifen (Nolvadex) | 5.5 | 10mg | 9.9mg | -1.3% | 96.50% | Lab F |
| 12 Dec 2025 | Alprostadil | 6.3 | 50mg | 47.9mg | -4.3% | 98.24% | Lab E |
| 12 Dec 2025 | Selank | 5.1 | 5mg | 5.4mg | +7.6% | 99.03% | Lab G |
| 12 Dec 2025 | SS-31 | 8.6 | 10mg | 10.5mg | +4.8% | 98.85% | Lab G |
| 12 Dec 2025 | Tadalafil (Cialis) | 7.4 | 20mg | 23.5mg | +17.6% | 98.47% | Lab G |
| 5 Dec 2025 | MK-677 (Ibutamoren) | 6.8 | 100mg | 120.7mg | +20.7% | 99.20% | Lab E |
| 5 Dec 2025 | Tamoxifen (Nolvadex) | 5.0 | 10mg | 11.2mg | +12.3% | 96.37% | Lab C |
| 23 Nov 2025 | Equipoise (Boldenone Undecylenate) | 6.2 | 100mg/ml | 106.5mg/ml | +6.5% | 97.98% | Lab B |
| 23 Nov 2025 | Estradiol Cypionate | 6.9 | 300mg/ml | 369.6mg/ml | +23.2% | 95.09% | Lab E |
| 23 Nov 2025 | MK-677 (Ibutamoren) | 8.6 | 100mg | 85.8mg | -14.2% | 95.84% | Lab C |
| 23 Nov 2025 | Trenbolone Acetate Raw | 7.6 | 500g | 582.0g | +16.4% | 97.02% | Lab E |
| 17 Nov 2025 | Retatrutide 30mg Pen Kit | 8.8 | 2mg | 2.5mg | +23.4% | 98.93% | Lab B |
| 17 Nov 2025 | Tamoxifen (Nolvadex) | 4.0 | 10mg | 8.8mg | -11.6% | 95.90% | Lab G |
| 5 Nov 2025 | DSIP | 7.0 | 5mg | 6.1mg | +22.8% | 96.61% | Lab B |
| 5 Nov 2025 | KPV Oral | 8.1 | 50mg | 51.4mg | +2.8% | 96.48% | Lab B |
| 5 Nov 2025 | Tadalafil (Cialis) | 4.5 | 10mg | 12.4mg | +23.9% | 99.83% | Lab E |
| 4 Nov 2025 | Estradiol Cypionate | 5.9 | 200mg/ml | 244.9mg/ml | +22.4% | 96.46% | Lab D |
| 4 Nov 2025 | PE 22-28 | 6.8 | 15mg | 18.3mg | +21.9% | 95.37% | Lab E |
| 4 Nov 2025 | Retatrutide 30mg Pen Kit | 7.9 | 30mg | 32.1mg | +6.8% | 97.72% | Lab A |
| 4 Nov 2025 | Retatrutide 5mg + Cagrilintide 5mg Blend | 7.7 | 15mg | 17.1mg | +13.8% | 96.95% | Lab G |
| 4 Nov 2025 | SNAP-8 | 6.8 | 30mg | 36.5mg | +21.6% | 99.62% | Lab D |
| 4 Nov 2025 | SS-31 | 4.0 | 10mg | 12.3mg | +22.9% | 97.54% | Lab G |
| 17 Oct 2025 | Pinealon | 4.0 | 30mg | 36.9mg | +23.1% | 97.56% | Lab G |
| 17 Oct 2025 | Retatrutide 30mg Pen Kit | 6.6 | 10mg | 8.8mg | -12.1% | 95.79% | Lab F |
| 9 Oct 2025 | Anavar (Oxandrolone) | 7.7 | 10mg | 9.9mg | -1.1% | 96.50% | Lab E |
| 9 Oct 2025 | DSIP | 8.0 | 20mg | 18.0mg | -9.9% | 99.20% | Lab F |
| 9 Oct 2025 | Selank | 4.0 | 2mg | 2.3mg | +13.0% | 98.86% | Lab D |
| 9 Oct 2025 | Sustanon Blend Raw | 7.3 | 500g | 616.7g | +23.3% | 98.77% | Lab C |
| 3 Oct 2025 | Estradiol Cypionate | 7.6 | 250mg/ml | 275.7mg/ml | +10.3% | 98.16% | Lab D |
| 3 Oct 2025 | PE 22-28 | 4.3 | 15mg | 14.3mg | -4.4% | 99.02% | Lab F |